1. AODWE-007 Real world data on the effectiveness and safety of vedolizumab in the treatment of crohn's disease and ulcerative colitis: the edinburgh experience. (17th June 2017) Authors: Plevris, N; Manship, TA; Deekae, A; Jones, GR; Noble, CL; Satsangi, J; Shand, AG; Arnott, ID; Lees, CW Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-002 Predicting Outcome In Acute Ulcerative Colitis: Comparison Of The Travis And Ho Scores Using Uk Ibd Audit Data. (9th June 2014) Authors: Churchhouse, AM; Lynch, RW; Protheroe, A; Arnott, ID Journal: Gut Issue: Volume 63(2014)Supplement 1 Page Start: A1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PTH-099 A novel approach to the implementation of biosimilar infliximab ct-p13 for the treatment of ibd utilising therapeutic drug monitoring: the edinburgh experience. (17th June 2017) Authors: Plevris, N; Manship, TA; Deekae, A; Jones, GR; Noble, CL; Satsangi, J; Shand, AG; Arnott, ID; Lees, CW Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PWE-070 Initial experience of thiopurine metabolite measurements in the management of ibd in edinburgh. (22nd June 2015) Authors: Singh, P; Noble, CL; Shand, AG; Arnott, ID; Lees, CW; Satsangi, J; Kennedy, NA Journal: Gut Issue: Volume 64(2015)Supplement 1 Page Start: A242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗